-1
Dokumente im Korb
Helmholtz Zentrum München
|
Imprint
PuSH - Publication Server of Helmholtz Zentrum München
Navigation
Home
Deutsch
Research
Advanced Search
Browse by ...
... Journal
... Publication Type
... Research Data
... Publication Year
Publication overview
Support & Contact
Contact persons
Help
Data protection
Karlas, A.
;
Nunes, A.
; Driessen, W.* ;
Liapis, E.
;
Reber, J.
Multi-aspect optoacoustic imaging of breast tumors under chemotherapy with exogenous and endogenous contrasts: Focus on apoptosis and hypoxia.
Biomedicines
9
:1696 (2021)
Publ. Version/Full Text
DOI
PMC
Open Access Gold
as soon as is submitted to ZB.
Abstract
Metrics
Extra information
Breast cancer is a complex tumor type involving many biological processes. Most chemotherapeutic agents exert their antitumoral effects by rapid induction of apoptosis. Another main feature of breast cancer is hypoxia, which may drive malignant progression and confer resistance to various forms of therapy. Thus, multi-aspect imaging of both tumor apoptosis and oxygenation in vivo would be of enormous value for the effective evaluation of therapy response. Herein, we demonstrate the capability of a hybrid imaging modality known as multispectral optoacoustic tomography (MSOT) to provide high-resolution, simultaneous imaging of tumor apoptosis and oxygenation, based on both the exogenous contrast of an apoptosis-targeting dye and the endogenous contrast of hemoglobin. MSOT imaging was applied on mice bearing orthotopic 4T1 breast tumors before and following treatment with doxorubicin. Apoptosis was monitored over time by imaging the distribution of xPLORE-APOFL750©, a highly sensitive poly-caspase binding apoptotic probe, within the tumors. Oxygenation was monitored by tracking the distribution of oxy- and deoxygenated hemoglobin within the same tumor areas. Doxorubicin treatment induced an increase in apoptosis-depending optoacoustic signal of xPLORE-APOFL750© at 24 h after treatment. Furthermore, our results showed spatial correspondence between xPLORE-APO750© and deoxygenated hemoglobin. In vivo apoptotic status of the tumor tissue was independently verified by ex vivo fluorescence analysis. Overall, our results provide a rationale for the use of MSOT as an effective tool for simultaneously investigating various aspects of tumor pathophysiology and potential effects of therapeutic regimes based on both endogenous and exogenous molecular contrasts.
Altmetric
Additional Metrics?
[➜Log in]
Tags
Annotations
Special Publikation
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Corresponding Author
Keywords
Msot ; Breast Cancer ; Contrast Agent ; Molecular Imaging ; Multispectral Optoacoustic Tomography ; Photoacoustics; Tomography; Adriamycin; Pet/ct; Death
Keywords plus
ISSN (print) / ISBN
2227-9059
e-ISSN
2227-9059
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Journal
Biomedicines
Quellenangaben
Volume: 9,
Issue: 11,
Pages: ,
Article Number: 1696
Supplement: ,
Series
Publisher
MDPI
Publishing Place
Basel, Switzerland
University
University place
Faculty
Publication date
0000-00-00
Application number
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institute of Biological and Medical Imaging (IBMI)
Grants